Search filters

List of works by Mary Allen

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

scientific article published on 22 May 2020

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

scientific article published on 01 November 2019

Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States

scientific article published on December 2005

Current advances and challenges in HIV-1 vaccines

scientific article

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? ⬇️

scientific article published on January 29, 2013

First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine

scientific article published on 13 September 2012

HIV vaccines: Biological and clinical considerations

article

High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects

article

Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.

scientific article published on October 2007

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials

scientific article

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine

article

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa.

scientific article

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

article

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research.

scientific article published on 22 October 2009

P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations

article

Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults

scientific article

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

scientific article published on 08 July 2013

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

scientific article

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

scientific article published on 24 February 2020

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

scientific article

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

scientific article published on 14 November 2017

Social impact of preventive HIV vaccine clinical trial participation: A model of prevention, assessment and intervention

article

Trial-related discrimination in HIV vaccine clinical trials.

scientific article published in May 2001

Paulina is supported by:

About Paulina

Help